Clinical Corner

We provide clinical information and insights to help you serve plan members, manage costs and avoid surprises. Find essential safety recalls, new drug announcements and other clinical news here.

Contact your Account Manager or Clinical Account Executive for additional details or if you have specific questions.

Looking for more CastiaRx news?
Visit The Edge

new April 2020 drug update

This monthly update highlights recently approved brand and generic drugs as well as new to market therapies. Read More

new Withdrawal of all Ranitidine and Zantac Products

The FDA is requesting the immediate withdrawal of all prescription and over-the-counter (OTC) ranitidine drugs from the market due to increased suspicion of NDMA in the products. Read More 

new Diabetes Medications with Heart Benefits

An increasing number of diabetes medications have been proven to reduce the risk of having a heart attack or stroke. Read More

New Drug Updates

New drug approved for HIV prevention 01/24/20

The FDA approved Descovy® for use as a pre-exposure prophylaxis (PrEP) medication to reduce the risk of HIV infection.

New drug approved for migraine 01/24/20

Reyvow© is the first and only drug in a new class of acute treatment for migraine approved by the FDA.

New drug approved for acne vulgaris 01/22/20

The FDA approved a new acne topical treatment, Aklief®, the first new retinoid molecule to be approved in over 20 years.

New drug approved for cystic fibrosis 11/27/19

The FDA approved a new breakthrough therapy, Trikafta™, which has the potential to benefit up to 90% of cystic fibrosis patients.

New drug approved for treating HSDD 10/18/19

VylessiTM is the first medication on the market that offers an as-needed solution for hypoactive sexual desire disorder (HSDD).

See Archives

New Generic Drugs

Generic Approval. Now What? 10/04/19

The big switch from brand to generic is a seamless process. Learn how the choices made during plan setup guide the transition.

First generics of Lyrica® available 09/11/19

The FDA approved nine generic versions of pregabalin that are now available at a significantly lower price than Lyrica.

First generic of Revatio® is approved 07/16/19

Novitium Pharma received approval from the FDA for the first generic sildenafil suspension to treat pulmonary arterial hypertension.

Generic versions of Vesicare® available 07/16/19

Teva launched its generic version of the overactive bladder drug and a month later additional manufacturers followed suit.

Authorized generic of Humalog® available 05/16/19

The lower-priced generic, Insulin Lispro, is commercially available as an authorized generic of Humalog.

See Archives

Safety Updates

Withdrawal of all Ranitidine and Zantac Products 04/07/20

The FDA is requesting the immediate withdrawal of all prescription and over-the-counter (OTC) ranitidine drugs from the market due to increased suspicion of NDMA in the products.

Recall of Phenytoin Oral Suspension 02/24/20

Two lots of the anti-epileptic drug are being recalled due to potential for inaccurate dosing.

Withdrawal of Belviq and Belviq XR 02/17/20

The FDA has requested the voluntary withdrawal of Belviq and Belviq XR from the market due to increased occurrence of cancer.

Recall of Lamotrigine tablets 01/20/20

One lot of the epilepsy and bipolar disorder medication is being voluntarily recalled due to cross-contamination with another substance.

Recall of Alprazolam tablets 10/31/19

One lot of the anxiety management medication is being recalled due to the potential presence of a foreign substance.

See Archives

Important Clinical News

April 2020 drug update 05/04/20

This monthly update highlights recently approved brand and generic drugs as well as new to market therapies.

Diabetes Medications with Heart Benefits 04/07/20

An increasing number of diabetes medications have been proven to reduce the risk of having a heart attack or stroke.

March 2020 drug update 04/06/20

This monthly update highlights recently approved brand and generic drugs as well as new to market therapies.

Brand Pipeline Forecast – 2020 Q1 03/25/20

This quarterly drug development pipeline highlights new and emerging therapies, including both traditional and specialty medications.

Generic Pipeline Forecast – 2020 Q1 03/25/20

This quarterly drug pipeline includes first-time generic drugs seeking FDA approval in the next two years.

See Archives